The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

The Attenuation of Pain Behavior and Serum COX-2 Concentration by Curcumin in a Rat Model of Neuropathic Pain

  • Zanjani, Taraneh Moini (Department of Pharmacology & Neuroscience Research Center, Shahid Beheshti Medical University) ;
  • Ameli, Haleh (Department of Pharmacology & Neuroscience Research Center, Shahid Beheshti Medical University) ;
  • Labibi, Farzaneh (Department of Immunology, Shahid Beheshti Medical University) ;
  • Sedaghat, Katayoun (Endocrine Physiology Research Center, Shahid Beheshti Medical University) ;
  • Sabetkasaei, Masoumeh (Department of Pharmacology & Neuroscience Research Center, Shahid Beheshti Medical University)
  • Received : 2014.03.18
  • Accepted : 2014.06.08
  • Published : 2014.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Neuropathic pain is generally defined as a chronic pain state resulting from peripheral and/or central nerve injury. There is a lack of effective treatment for neuropathic pain, which may possibly be related to poor understanding of pathological mechanisms at the molecular level. Curcumin, a therapeutic herbal extract, has shown to be effectively capable of reducing chronic pain induced by peripheral administration of inflammatory agents such as formalin. In this study, we aimed to show the effect of curcumin on pain behavior and serum COX-2 level in a Chronic Constriction Injury (CCI) model of neuropathic pain. Methods: Wistar male rats (150-200 g, n = 8) were divided into three groups: CCI vehicle-treated, sham-operated, and CCI drug-treated group. Curcumin (12.5, 25, 50 mg/kg, IP) was injected 24 h before surgery and continued daily for 7 days post-surgery. Behavioral tests were performed once before and following the days 1, 3, 5, 7 after surgery. The serum COX-2 level was measured on day 7 after the surgery. Results: Curcumin (50 mg/kg) decreased mechanical and cold allodynia (P < 0.001) and produced a decline in serum COX-2 level (P < 0.001). Conclusions: A considerable decline in pain behavior and serum COX-2 levels was seen in rat following administration of curcumin in CCI model of neuropathic pain. High concentration of Curcumin was able to reduce the chronic neuropathic pain induced by CCI model and the serum level of COX-2.

Keywords

References

  1. Blackburn-Munro G. Pain-like behaviours in animals - how human are they? Trends Pharmacol Sci 2004; 25: 299-305. https://doi.org/10.1016/j.tips.2004.04.008
  2. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001; 429: 23-37. https://doi.org/10.1016/S0014-2999(01)01303-6
  3. Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron 2006; 52: 77-92. https://doi.org/10.1016/j.neuron.2006.09.021
  4. Dray A. Neuropathic pain: emerging treatments. Br J Anaesth 2008; 101: 48-58. https://doi.org/10.1093/bja/aen107
  5. Suzuki R, Dickenson AH. Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury. Exp Neurol 2006; 198: 72-80. https://doi.org/10.1016/j.expneurol.2005.10.032
  6. Epstein J, Sanderson IR, Macdonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 2010; 103: 1545-57. https://doi.org/10.1017/S0007114509993667
  7. Sharma S, Kulkarni SK, Agrewala JN, Chopra K. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol 2006; 536: 256-61. https://doi.org/10.1016/j.ejphar.2006.03.006
  8. Oh SW, Cha JY, Jung JE, Chang BC, Kwon HJ, Lee BR, et al. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-${\kappa}$B inhibition. J Ethnopharmacol 2011; 136: 414-21. https://doi.org/10.1016/j.jep.2010.07.026
  9. Sharma S, Chopra K, Kulkarni SK. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res 2007; 21: 278-83. https://doi.org/10.1002/ptr.2070
  10. Mittal N, Joshi R, Hota D, Chakrabarti A. Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Phytother Res 2009; 23: 507-12. https://doi.org/10.1002/ptr.2662
  11. Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: biological actions and medicinal applications. Curr Sci 2004; 87: 44-53.
  12. Stock JL, Shinjo K, Burkhardt J, Roach M, Taniguchi K, Ishikawa T, et al. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J Clin Invest 2001; 107: 325-31. https://doi.org/10.1172/JCI6749
  13. Luo C, He ML, Bohlin L. Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial. Acta Pharmacol Sin 2005; 26: 926-33. https://doi.org/10.1111/j.1745-7254.2005.00150.x
  14. Neuss H, Huang X, Hetfeld BK, Deva R, Henklein P, Nigam S, et al. The ubiquitin- and proteasome-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibs. J Mol Med (Berl) 2007; 85: 961-70. https://doi.org/10.1007/s00109-007-0197-y
  15. Rainsford KD. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology 2006; 14: 120-37. https://doi.org/10.1007/s10787-006-1505-9
  16. Kimura T, Iwase M, Kondo G, Watanabe H, Ohashi M, Ito D, et al. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils. Int Immunopharmacol 2003; 3: 1519-28. https://doi.org/10.1016/S1567-5769(03)00179-6
  17. Rang HP, Dale MM, Ritter JM, Flower RJ. Anti-inflammatory and immunosuppressant drugs. In: Rang and Dale pharmacology. 6th ed. Edinburgh, Churchill Livingston. 2007, p 232.
  18. Bryant DM, Alldred A. Rheumatoid arthritis and osteoarthritis. In: Clinical pharmacy and therapeutics. 4th ed. Edited by Walker R, Whittlesea C. Edinburgh, Churchill Livingstone. 2007, pp 791-812.
  19. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci 2005; 1056: 206-17. https://doi.org/10.1196/annals.1352.010
  20. Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 2007; 595: 105-25. https://doi.org/10.1007/978-0-387-46401-5_3
  21. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-10. https://doi.org/10.1016/0304-3959(83)90201-4
  22. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107. https://doi.org/10.1016/0304-3959(88)90209-6
  23. Stuesse SL, Crisp T, McBurney DL, Schechter JB, Lovell JA, Cruce WL. Neuropathic pain in aged rats: behavioral responses and astrocytic activation. Exp Brain Res 2001; 137: 219-27. https://doi.org/10.1007/s002210000630
  24. Schaible HG, Ebersberger A, Natura G. Update on peripheral mechanisms of pain: beyond prostaglandins and cytokines. Arthritis Res Ther 2011; 13: 210. https://doi.org/10.1186/ar3305
  25. Kohli K, Ali J, Ansari MJ, Raheman Z. Curcumin: a natural antiinflammatory agent. Indian J Pharmacol 2005; 37: 141-7. https://doi.org/10.4103/0253-7613.16209
  26. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001; 21: 8370-7.
  27. Li Y, Zhang Y, Liu DB, Liu HY, Hou WG, Dong YS. Curcumin attenuates diabetic neuropathic pain by downregulating TNF-${\alpha}$ in a rat model. Int J Med Sci 2013; 10: 377-81. https://doi.org/10.7150/ijms.5224
  28. Jeon Y, Kim CE, Jung D, Kwak K, Park S, Lim D, et al. Curcumin could prevent the development of chronic neuropathic pain in rats with peripheral nerve injury. Curr Ther Res Clin Exp 2013; 74: 1-4. https://doi.org/10.1016/j.curtheres.2012.10.001
  29. Kim CE, Park ES, Jeon YH. Curcumin attenuates chronic constriction nerve injury-induced neuropathic pain in rats. Korean J Med Crop Sci 2008; 16: 183-7.
  30. Han YK, Lee SH, Jeong HJ, Kim MS, Yoon MH, Kim WM. Analgesic effects of intrathecal curcumin in the rat formalin test. Korean J Pain 2012; 25: 1-6. https://doi.org/10.3344/kjp.2012.25.1.1
  31. Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 2006; 30: 45-51. https://doi.org/10.1177/014860710603000145
  32. Yeon KY, Kim SA, Kim YH, Lee MK, Ahn DK, Kim HJ, et al. Curcumin produces an antihyperalgesic effect via antagonism of TRPV1. J Dent Res 2010; 89: 170-4. https://doi.org/10.1177/0022034509356169
  33. Tajik H, Tamaddonfard E, Hamzeh-Gooshchi N. Interaction between curcumin and opioid system in the formalin test of rats. Pak J Biol Sci 2007; 10: 2583-6. https://doi.org/10.3923/pjbs.2007.2583.2586
  34. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 2003; 9: 161-8. https://doi.org/10.1089/107555303321223035
  35. Orlando RA, Gonzales AM, Hunsaker LA, Franco CR, Royer RE, Vander Jagt DL, et al. Inhibition of nuclear factor kappaB activation and cyclooxygenase-2 expression by aqueous extracts of Hispanic medicinal herbs. J Med Food 2010; 13: 888-95. https://doi.org/10.1089/jmf.2009.1128
  36. Tegeder I, Niederberger E, Vetter G, Brautigam L, Geisslinger G. Effects of selective COX-1 and -2 inhibition on formalinevoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J Neurochem 2001; 79: 777-86.
  37. Vanegas H, Schaible HG. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord. Prog Neurobiol 2001; 64: 327-63. https://doi.org/10.1016/S0301-0082(00)00063-0
  38. Kang G, Kong PJ, Yuh YJ, Lim SY, Yim SV, Chun W, et al. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase- 2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. J Pharmacol Sci 2004; 94: 325-8. https://doi.org/10.1254/jphs.94.325
  39. Hinz B, Brune K. Cyclooxygenase-2--10 years later. J Pharmacol Exp Ther 2002; 300: 367-75. https://doi.org/10.1124/jpet.300.2.367
  40. Ma W, Eisenach JC. Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury. Neuroscience 2003; 121: 691-704. https://doi.org/10.1016/S0306-4522(03)00495-0
  41. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009; 41: 40-59. https://doi.org/10.1016/j.biocel.2008.06.010

Cited by

  1. Curcumin, COX-2, and Protein p300/CBP vol.27, pp.4, 2014, https://doi.org/10.3344/kjp.2014.27.4.365
  2. Olanzapine Attenuates Mechanical Allodynia in a Rat Model of Partial Sciatic Nerve Ligation vol.28, pp.3, 2015, https://doi.org/10.3344/kjp.2015.28.3.185
  3. Curcumin upregulates S100 expression and improves regeneration of the sciatic nerve following its complete amputation in mice vol.11, pp.8, 2016, https://doi.org/10.4103/1673-5374.189196
  4. Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases vol.20, pp.4, 2016, https://doi.org/10.1007/s40291-016-0202-7
  5. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms? vol.8, pp.1, 2017, https://doi.org/10.1002/jcsm.12140
  6. Curcumin Inhibits Monocyte Chemoattractant Protein-1 Expression in TNF-α induced Astrocytes Through AMPK Pathway vol.43, pp.4, 2018, https://doi.org/10.1007/s11064-018-2479-x
  7. Effects of oral curcumin ingested before or after eccentric exercise on markers of muscle damage and inflammation pp.09057188, 2019, https://doi.org/10.1111/sms.13373
  8. Medicinal herbs in the treatment of neuropathic pain: a review vol.21, pp.4, 2014, https://doi.org/10.22038/ijbms.2018.24026.6021
  9. Objective clinical pain analysis using serum cyclooxygenase-2 and inducible nitric oxide synthase in American patients vol.484, pp.None, 2014, https://doi.org/10.1016/j.cca.2018.06.005
  10. Analgesic effects of soluble epoxide hydrolase inhibitor in K/BxN serum transfer arthritis mouse model vol.14, pp.1, 2014, https://doi.org/10.17085/apm.2019.14.1.76
  11. Efficacy of curcuminoids for reducing postoperative pain after laparoscopic gynecologic surgery: A pilot randomized trial vol.16, pp.4, 2014, https://doi.org/10.1515/jcim-2018-0224
  12. Efficacy of curcuminoids for reducing postoperative pain after laparoscopic gynecologic surgery: A pilot randomized trial vol.16, pp.4, 2014, https://doi.org/10.1515/jcim-2018-0224
  13. Antinociceptive and neuroprotective effects of bromelain in chronic constriction injury-induced neuropathic pain in Wistar rats vol.33, pp.1, 2014, https://doi.org/10.3344/kjp.2020.33.1.13
  14. Curcumin Diglutaric Acid, a Prodrug of Curcumin Reduces Pain Hypersensitivity in Chronic Constriction Injury of Sciatic Nerve Induced-Neuropathy in Mice vol.13, pp.9, 2014, https://doi.org/10.3390/ph13090212
  15. Key Developments in the Potential of Curcumin for the Treatment of Peripheral Neuropathies vol.9, pp.10, 2014, https://doi.org/10.3390/antiox9100950
  16. Effects of Curcumin and Its Different Formulations in Preclinical and Clinical Studies of Peripheral Neuropathic and Postoperative Pain: A Comprehensive Review vol.22, pp.9, 2014, https://doi.org/10.3390/ijms22094666